Adze Biotechnology Inc — Form D/A
Adze Biotechnology Inc of CORAL GABLES, FL, a company, filed a Form D amendment with the SEC on 2025-02-19. The offering totals $15.0M, of which $6.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-19
- Form: D/A
- Accession: 0001787508-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $6.1M
- Remaining: $8.9M
- Minimum investment: $25K
- Investors: 21
- Date of first sale: 2023-03-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-475802
Issuer
- Name: Adze Biotechnology Inc
- CIK: 0001787508
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2332 GALIANO STREET, 2ND FL, CORAL GABLES, FL, 33134
- Phone: 9177439401
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Gloria J Olivier | Director | Rochester, MN |
| Kenneth J Templin | Executive Officer | Oak Park, IL |
| Brendan Patrick Kenny | Director | Edmonton, A0 |
| Sidney Hopps | Director | Miami, FL |
| Sidney Hopps | Executive Officer | Miami, FL |
| Gabriel Patrick Raviv | Director | Glenview, IL |
| G. Patrick Sage, II | Director | Kalamazoo, MI |
| Richard Schuler | Director | Oak Park, IL |
| Patrick G Sage, II | Director | Oak Park, IL |
| Kenneth Templin | Director | Oak Park, IL |
| Kenneth Templin | Executive Officer | Oak Park, IL |
| Gabriel G Raviv | Director | Oak Park, IL |
| G. Patrick Sage | Director | Oak Park, IL |
Other filings by this issuer (9)
More